How Hers uses a BMI-over-27 callout to open a Wegovy pill ad | Fluid
Esc

How Hers uses a BMI-over-27 callout to open a Wegovy pill ad

A 36-second Hers video that started running on Meta on Oct 12, 2026. An actor climbs outdoor brick stairs holding the rail under a caption calling out women with a BMI over 27 for whom nothing's working. The voiceover pitches the once-daily Wegovy pill with no injection, insurance or in-person visits. It links to the Wegovy consultation page.

Hers
53 creatives lead here1 / 53
Hers · Wegovy consultation

Public destination captured October 22, 2026. The reference retains the page layout and loaded imagery; shopping-extension UI is removed. Offers may change. No health answers were supplied.

Hers: full page screenshot

Get started today

Visual reference: Nothing’s working? BMI-led hook. A three-question prequalification page introduces treatment format, motivation and wider goals before the shared weight-loss questionnaire. Price, creator, AI-care and food-noise messages all converge here. Compare the creative with the destination and explore the other ads sharing this route.

Brand
Hers
Observed offer
Medication from $149/mo, if prescribed; membership $39 first month then $149/mo
Creative angle
Product benefits
Page type
Consultation entry
Ad format
Video · 0:36
Listed start date
Oct 12, 2026
Captured
Oct 22, 2026
Library ID
1083398931204344
Destination
forhers.com

Selected for its design and offer structure. Ad performance isn’t available in this collection.

What this ad does well

The opening caption is a precise callout: it names who the ad is for (women with a BMI over 27) and what they're feeling (nothing's working), so the right viewer knows in one second that this is about them. The stair-climbing shot shows effort without being cruel, which is a hard balance in this category. The voiceover then uses a what-would-happen question to introduce the pill, and stacks the format advantages (no injection needed, no insurance required, no in-person visits). It also states the membership price on screen ($39 first month, then $149/month) instead of leaving it in the caption.

What's missing

After the strong callout, the ad drops the woman on the stairs and switches to general claims, so the person the viewer identified with disappears. The weight-loss figures rest on trial fine print, and the reason to act (the sooner you start, the sooner you see results) is generic. If you make one like this, keep the same person through the whole video and show a small, believable moment later on (taking the pill with breakfast, answering the intake on her phone). That keeps the viewer's attention on someone like them instead of on a list.

Beat by beat

  1. 0-4s
    An actor climbs outdoor brick stairs holding the rail, under a caption calling out women with a BMI over 27 for whom nothing's working.

    Naming the exact audience and frustration makes the right viewer stop.

  2. 4-12s
    The voiceover asks what would happen if you took Wegovy, a once-daily GLP-1 pill, citing a trial figure on screen.

    A question format introduces the product and its main claim together.

  3. 12-24s
    It calls Wegovy the most affordable FDA-approved semaglutide and shows the membership price, then lists no injection, no insurance and no in-person visits.

    Price and format answer the two biggest practical objections.

  4. 24-36s
    A pill bottle appears and the voiceover prompts the online consultation.

    It ends on the product and a single next step.

The offer

The video shows membership at $39 for the first month, then $149/month. The copy adds medication from $149/mo if prescribed, billed separately.

Where it sends people

The ad sends people to Hers's Wegovy consultation entry page, a focused page whose hero opens the intake with a treatment-preference question that includes a pill answer. That's a direct continuation of a pill-focused ad. The options carousel shows a "from" monthly price per medication and eligibility tags, which echoes the BMI callout's sense of who qualifies, and the FAQ covers eligibility in detail. The page doesn't repeat the BMI line near the top, so someone wondering whether they qualify has to scroll to the eligibility pill or FAQ to find out.

The page it sends people to: How Hers starts its Wegovy consultation inside the page hero

Hers's Wegovy consultation page opens with the first intake question in a card over the hero, then scrolls through medication cards with "from" monthly prices, a results band, membership perks, a dosing schedule and a long FAQ. 53 ads in the Fluid library send people here, including price-led, food-noise, membership-value and creator-story ads.

How the page is built

  1. 01
    Announcement bar and header

    A single line on affordability sits above a logo-only header, so the price question gets a nod before anything else and there's no navigation to wander off into.

  2. 02
    Hero with intake card

    A full-bleed portrait with a descending line-graph overlay frames a centered card that asks whether the visitor already has a treatment in mind, answering "where do I start?" with three one-tap choices.

  3. 03
    Options carousel

    Horizontal medication cards show the product, prescription and availability tags, a "from" monthly price and a safety link, answering "what are my options and what do they cost?" with pricing and eligibility fine print below.

  4. 04
    Results band

    An outdoor photo of two women carries a headline, three check items and a frosted card with a large outcome figure, which is the page's main answer to "what could this look like for me?"

  5. 05
    Membership

    A four-photo collage (provider, app, product, smart scale) sits over five check-row perks, answering "what am I paying the membership for?"

  6. 06
    Health-marker carousel

    Dark cards pair data-visualization illustrations with short benefit claims and footnotes, covering what the page says treatment can involve beyond the scale.

  7. 07
    Dosing schedule

    A chart of example monthly dose increases and a numbered four-step accordion with dose pills explain how treatment eases in, answering "what happens month to month?"

  8. 08
    FAQ

    A long accordion covers membership, cost, options, visits, insurance, HSA, eligibility, switching and side effects, catching the practical objections that are left.

  9. 09
    Footer

    Disclaimers, an app-download card with a QR code, a pharmacy certification badge and a sister-brand card close the page with trust signals and legal detail.

The first fixes we would make

  1. The membership fee is separate from the medication price, and that detail lives in fine print under the carousel. Put the combined monthly cost (medication plus membership) right under each "from" price, so a visitor who came from a price ad sees the number they'll actually pay before they start the intake.
  2. Creator-story ads send people here, but the page has no member stories or reviews to pick up that voice; the results band shows a single outcome figure instead. Add a short strip of member stories (with the same disclaimers Hers uses elsewhere) near the results band, so someone who clicked a creator's documentary finds people like that creator on the page.

Read the full breakdown of this page

Three hooks you could test

  • Lead with the uncomfortable problem. “If you've done everything right and nothing's changing, this is for you.”
  • Call out the habit you're replacing. “No more needles in the fridge. This one's a pill.”
  • Show a specific moment of use. “One pill with my morning coffee, and that's the whole routine.”

What to borrow for your brand

  • Open with a callout that names your exact audience and their frustration in one caption, so the right people self-select in the first second.
  • Put the first-month price on screen, not only in the caption, since it answers the cost objection before viewers scroll away.
  • Choose an opening shot that shows effort or friction without mocking the viewer, which keeps a sensitive topic respectful.

Transcript

If you're a woman with a BMI over 27 and nothing's working, you need to hear this. What would happen if you took Wegovi, a once daily GLP one pill, to lose up to 20% of your body weight? You'd get the most affordable FDA approved semaglutide, clinically proven to promote weight loss and taken only once a day. No injection needed, no insurance required, no in-person visits, just 100% online. Thanks to the once daily WegoV pill with hers. The sooner you start, the sooner you start seeing results. Take the online consultation to get started.
Text on screen
  • If you're a woman with a BMI over 27
  • and nothing's working
  • Actor portrayal
  • you need to hear THIS!
  • What would happen if
  • you took Wegovy®
  • a once-daily GLP-1 pill
  • to lose up to 20% of
  • your body weight"?
  • People lost an average of 14% body weight at
  • 64 weeks in a clinical trial of Wegory"
  • *in a 71-wesk einical study of Wegey? cral semaglitide (25mg), 27.5% of schults with
  • overw
  • tor obesity lost 220% body weight.at wank 64, alongside dut and earchie
  • dual results may vary. Stopping treatsent may result in weight regain.
  • You'd get the most affordable
  • FDA-approved semaglutide"
  • Membership required: $39 for the first month,
  • then $149/month.
  • joey, cral semaglutide (25mg), 27.9%% of adults with
  • ht or obesity lost ≥20% body weight at week 64, alon
  • de diet and exercise.
  • Individual results may vary Stopping tre
  • eight regain.
  • ad on pu
  • pety of the lowest atarting
  • ly, if prescribed. An actio
  • com toda Price inclades
  • at Sta/month thereafter? M
  • 2539 for the first month
  • et inclada or guaranted a
  • * Medication la not ay
  • a i bot incladed.
  • NOC 0168-4415-11
  • wegovy 1.5 mg
  • (semaglutide) Tablets
  • 30 tablets
  • then $149month.
  • Tin a 71-week clinical study of Wegory" oral semaglutide (25mg). 27.9% of adults with
  • overelight or obesity lost 220% body weight at week 64, alongside diet and earcise.

One of 125 Hers ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.